Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. 

Biotechnology

Arvinas

John Houston

Janet Wang

John Obourn

Shelley Diaz

Charlie Romano

David Loomis

Christopher Beck

Brad Lanoue

Kelly Page

Paul McInulty

Janice Kapty

Steve Weiss

Randy Teel

Marcia Dougan Moore

Kimberly Wehger

John A. Grosso

Jeff Boyle

Eric Masson

Angela M. Cacace

John Northcott

Lisa Sinclair

Sean Cassidy

Ian Taylor

Leadership Team

Senior Management

Scientific and Clinical Research

Management

Biotechnology Operations

Clinical and Commercial Strategy

Development Operations and Support

Talent Acquisition

Teams at Arvinas